No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
MXL240517C25000
- 0.26
- +0.23+766.67%
15min DelayClose May 13 16:00 ET
0.26High0.26Low
0.26Open0.03Pre Close1 Volume621 Open Interest25.00Strike Price26.00Turnover215.47%IV35.08%PremiumMay 17, 2024Expiry Date0.00Intrinsic Value100Multiplier4DDays to Expiry0.26Time Value100Contract SizeAmericanOptions Type0.1308Delta0.0486Gamma71.92Leverage Ratio-0.1039Theta0.0003Rho9.41Eff Leverage0.0043Vega
Intraday
- 5D
- 1D
News
MaxLinear, Inc. Announces Financial Conference Participation for the Second Quarter 2024
MaxLinear, Inc. (NASDAQ:MXL), a leading provider of RF, analog, digital and mixed-signal integrated circuits, today announced that it will participate in the following financial conferences in the second quarter of
Health Check: How Prudently Does MaxLinear (NASDAQ:MXL) Use Debt?
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously said that 'Volatility is far from synonymous with risk.' It's only natural to co
MaxLinear, Inc. (NASDAQ:MXL) Q1 2024 Earnings Call Transcript
MXL, COLM and SPSC Are Among After Hour Movers
Should You Investigate MaxLinear, Inc. (NASDAQ:MXL) At US$20.93?
Research Alert: CFRA Keeps Hold Opinion On Shares Of Maxlinear, Inc.
CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We up our 12-month target to $21 from $1
Comments
The decline in share price and revenue indicates unresolved challenges for MaxLinear. Investors may be hoping for future growth or cost cutting. However, long term share price weakness can be a bad sign, suggesting a need for a turnaround.
MaxLinear (NASDAQ:MXL) Shareholders Are up 8.8% This Past Week, but Still in the Red Over the Last Year 1
MaxLinear's net cash position suggests a light debt load, but future earnings will determine its balance sheet health. The company's shrinking revenue and pre-interest, pre-tax loss over the past year are worrisome. Despite positive free cash flow, the absence of positive EBIT makes the stock somewhat risky.
MaxLinear's lower P/S suggests the market is not optimistic about the firm's future revenue growth. Further decline in revenues may push the P/S lower, possibly hindering any significant rise in stock price in the near term.
MaxLinear's performance and decline in revenue point to a need for growth or cost-cutting to draw investment interest. Its underperformance this year against a 0.9% annual loss over five years invites scrutiny before investment.
3
$MaxLinear(MXL.US$ on move ! good job all
Read more